Articles
A Reform to Help the Uninsured, and Decrease Healthcare Costs
A newly published paper in The Milbank Quarterly adds to the growing body of evidence that the federal 340B Drug Pricing Program has strayed far from its original purpose, strengthening the case for meaningful congressional reform. In a recent RealClearMarkets commentary, Market Institute Senior Fellow Norm Singleton highlights Stretching Scarce Read more…